Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
City of Hope - Duarte, Duarte, California Rocky Mountain Cancer Centers, Aurora, Colorado Medical Oncology Hematology Consultants, Newark, Delaware Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia Mayo Clinic Cancer Center (MCCC) - Rochester, Rochester, Minnesota